Ukraine fines Sanofi-Aventis subsidiary for restrictive practices

Ukraine’s antitrust watchdog has fined Sanofi-Aventis Ukraine and two of its distributors for a scheme that allegedly undercut generic drugs suppliers in public tenders.


Get unlimited access to all Global Competition Review content